Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darrick Carter

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
Journal of Virology|August 21, 2015
Intracellular Signaling and Desmoglein 2 Shedding Triggered by Human Adenoviruses Ad3, Ad14, and Ad14P1Hongjie Wang, Corinne Ducournau, Kamola Saydaminova, et al.
Journal of Pharmaceutical Sciences|June 2, 2019
A Spray-Dried Combination of Capreomycin and CPZEN-45 for Inhaled Tuberculosis TherapyRagan A Pitner, Phillip G Durham, Ian E Stewart, et al.
Therapeutic Advances in Vaccines|May 19, 2017
Accounting for adjuvant-induced artifacts in the characterization of vaccine formulations by polyacrylamide gel electrophoresisVirginie Jakob, Livia Brunner, Christophe Barnier-Quer, et al.
Infection and Immunity|February 19, 2015
Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoesKailash P Patra, Fengwu Li, Darrick Carter, et al.
Clinical and Vaccine Immunology : CVI|December 24, 2010
Insight toward early diagnosis of leprosy through analysis of the developing antibody responses of Mycobacterium leprae-infected armadillosMalcolm S Duthie, Richard W Truman, Wakako Goto, et al.
Vaccine|September 30, 2009
Optimized subunit vaccine protects against experimental leishmaniasisSylvie Bertholet, Yasuyuki Goto, Lauren Carter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 18, 2018
Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune ResponsesEmilie Seydoux, Hong Liang, Natasha Dubois Cauwelaert, et al.
Vaccine|July 9, 2016
Recombinant polymorphic membrane protein D in combination with a novel, second-generation lipid adjuvant protects against intra-vaginal Chlamydia trachomatis infection in miceWayne Paes, Naj Brown, Andrzej M Brzozowski, et al.
Journal of Nanobiotechnology|April 29, 2014
A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7Christopher B Fox, Sandra J Sivananthan, Malcolm S Duthie, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|July 13, 2018
<i>Schistosoma mansoni</i> antigen Sm-p80: prophylactic efficacy using TLR4 agonist vaccine adjuvant glucopyranosyl lipid A-Alum in murine and non-human primate modelsWeidong Zhang, Gul Ahmad, Adebayo J Molehin, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Journal of Virology|August 21, 2015
Intracellular Signaling and Desmoglein 2 Shedding Triggered by Human Adenoviruses Ad3, Ad14, and Ad14P1Hongjie Wang, Corinne Ducournau, Kamola Saydaminova, et al.
Journal of Pharmaceutical Sciences|June 2, 2019
A Spray-Dried Combination of Capreomycin and CPZEN-45 for Inhaled Tuberculosis TherapyRagan A Pitner, Phillip G Durham, Ian E Stewart, et al.
Therapeutic Advances in Vaccines|May 19, 2017
Accounting for adjuvant-induced artifacts in the characterization of vaccine formulations by polyacrylamide gel electrophoresisVirginie Jakob, Livia Brunner, Christophe Barnier-Quer, et al.
Infection and Immunity|February 19, 2015
Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoesKailash P Patra, Fengwu Li, Darrick Carter, et al.
Clinical and Vaccine Immunology : CVI|December 24, 2010
Insight toward early diagnosis of leprosy through analysis of the developing antibody responses of Mycobacterium leprae-infected armadillosMalcolm S Duthie, Richard W Truman, Wakako Goto, et al.
Vaccine|September 30, 2009
Optimized subunit vaccine protects against experimental leishmaniasisSylvie Bertholet, Yasuyuki Goto, Lauren Carter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 18, 2018
Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune ResponsesEmilie Seydoux, Hong Liang, Natasha Dubois Cauwelaert, et al.
Vaccine|July 9, 2016
Recombinant polymorphic membrane protein D in combination with a novel, second-generation lipid adjuvant protects against intra-vaginal Chlamydia trachomatis infection in miceWayne Paes, Naj Brown, Andrzej M Brzozowski, et al.
Journal of Nanobiotechnology|April 29, 2014
A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7Christopher B Fox, Sandra J Sivananthan, Malcolm S Duthie, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|July 13, 2018
<i>Schistosoma mansoni</i> antigen Sm-p80: prophylactic efficacy using TLR4 agonist vaccine adjuvant glucopyranosyl lipid A-Alum in murine and non-human primate modelsWeidong Zhang, Gul Ahmad, Adebayo J Molehin, et al.
Pageof 11